Trials of oral bovine and rhesus rotavirus vaccines in Finland: a historical account and present status

  • T. Vesikari
Conference paper
Part of the Archives of Virology book series (ARCHIVES SUPPL, volume 12)


Live oral rotavirus vaccine strain RIT 4237, derived from group A bovine rotavirus NCDV, was given to human volunteers in Tampere, Finland in 1982. Efficacy studies of this vaccine in 6-12 month-old children gave results characteristic of the performance of oral rotavirus vaccines in general: 58% protective efficacy against any rotavirus gastroenteritis and 82% against “clinically significant” gastroenteritis. Four trials of RIT 4237 bovine rotavirus vaccine, one trial of group A RRV-1 rhesus rotavirus vaccine, and one trial of rhesus-human reassortant rotavirus vaccines D x RRV and DS1 x RRV were carried out between 1983-1989. A meta-analysis of the protective efficacy of these vaccines indicated a 67% (95% C.I. 55-77%) efficacy against moderately severe rotavirus disease and an 81% (95% C.I. 60-91%) efficacy against severe rotavirus disease. There was no apparent difference between bovine and rhesus-based rotavirus vaccines in the protective efficacy against severe rotavirus gastroenteritis. Problems associated with the use of any oral rotavirus vaccine include acid lability of the vaccine virus, which requires buffering, and a slight but significant interference of oral poliovirus vaccine with the uptake of rotavirus vaccine. In the near future, oral heterologous rotavirus vaccines may be available for prevention of severe rotavirus gastroenteritis.


Oral Poliovirus Vaccine Epidemic Season Reassortant Vaccine Rota Virus Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA, for the US Rotavirus Vaccine Efficacy Group (1995) Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. JAMA 273: 1191–1196PubMedCrossRefGoogle Scholar
  2. 2.
    Bernstein DI, Smith VE, Sander DS, Pax KA, Schiff GM, Ward RL (1990) Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis 162: 1055–1062PubMedCrossRefGoogle Scholar
  3. 3.
    Ceyhan M, Kanra G, Seçmeer G, Midthun K, Davidson BL, Zito ET, Vesikari T (1993) Take of rhesus-human reassortant tetravalent rotavirus vaccine in breast-fed infants. Acta Paediatr 82: 223–227PubMedCrossRefGoogle Scholar
  4. 4.
    Chiba S, Yokoyama T, Nakata S, Morita Y, Urasawa T, Taniguchi K, Urasawa S, Nakao T (1986) Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet 2: 417–421PubMedCrossRefGoogle Scholar
  5. 5.
    Clark HF, Borian FE, Plotkin SA (1990) Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC 3. J Infect Dis 161: 1099–1104PubMedCrossRefGoogle Scholar
  6. 6.
    Delem A, Lobmann M, Zygraich N (1984) A bovine rotavirus developed as a candicate vaccine for use in humans. J Biol Standard 12: 443–445CrossRefGoogle Scholar
  7. 7.
    DeMol P, Zissis G, Butzler J-P, Mutwewingabo A, André FE (1986) Failure of live attenuated oral rotavirus vaccine. Lancet 2: 108CrossRefGoogle Scholar
  8. 8.
    Georges-Courbot MC, Monges J, Siopathis MR, Roungon JB, Gresenguet G, Bellec L, Bouquety JC, Lanckriet C, Cadoz M, Hessel L, Gouvea V, Clark F, Georges AJ (1991) Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res Virol 142: 405–411PubMedCrossRefGoogle Scholar
  9. 9.
    Giammanco G, De Grandi V, Lupo L, Mistretta A, Pignato S, Teuween D, Bogaerst H, Andre FE (1988) Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine. Eur J Epidemiol 4: 121–123PubMedCrossRefGoogle Scholar
  10. 10.
    Hanlon P, Hanlon L, Marsh V, Byass P, Shenton F, Hassan-King M, Jobe O, Sillah H, Hayes R, M’Boge BH, Whittle HC, Greenwood BM (1987) A trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian children. Lancet 2: 1342–1345CrossRefGoogle Scholar
  11. 11.
    Ho M-S, Floyd RL, Glass RI, Pallansch MA, Jones B, Hamby B, Woods P, Penaranda ME, Kapikian AZ, Bohan G, Wilcox WD, Blumberg R (1989) Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity. Pediatr Infect Dis J 8: 692–996PubMedCrossRefGoogle Scholar
  12. 12.
    Ing DJ, Glass RI, Woods PA, Simonetti M, Pallansch MA, Wilcox WD, Davidson BL, Sievert AJ (1991) Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral poliovirus vaccine. Am J Dis Child 145: 892–897PubMedGoogle Scholar
  13. 13.
    Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T (1995) Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 13: 310–312PubMedCrossRefGoogle Scholar
  14. 14.
    Lanata CF, Black RE, del Aguila R, Gil A, Verastegui H, Gerna G, Flores J, Kapikian AZ, Andre FE (1989) Protection of Peruvian children gainst rotavirus diarrhea of specific serotypes by the RIT 4237 attenuated bovine rotavirus vaccine. J Infect Dis 159:452–459PubMedCrossRefGoogle Scholar
  15. 15.
    Migasena S, Simasathien S, Samakoses R, Pitisuttitham P, Sangaroon P, van Steenis G, Beuvery EC, Bugg H, Bishop R, Davidson BL, Vesikari T (1995) Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants. Vaccine 13: 168–174PubMedCrossRefGoogle Scholar
  16. 16.
    Pichichero ME (1990) Effect of breast-feeding on oral rotavirus vaccine seroconversion;a metaanalysis. J Infect Dis 162: 753–755PubMedCrossRefGoogle Scholar
  17. 17.
    Ruuska T, Vesikari T, Delem A, André FE, Beards GM, Flewett TH (1990) Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: Correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period. Scand J Infect Dis 22: 269–278PubMedCrossRefGoogle Scholar
  18. 18.
    Ruuska T, Vesikari T (1990) Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 20: 259–267CrossRefGoogle Scholar
  19. 19.
    Treanor JJ, Clark F, Pichichero M, Christy C, Gouvea V, Shrager D, Palazzo S, Offit P (1995) Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants. Pediatr Infect Dis J 14: 301–307PubMedCrossRefGoogle Scholar
  20. 20.
    Vesikari T (1993) Clinical trials of live oral rotavirus vaccines: the Finnish experience. Vaccine 11: 255–261PubMedCrossRefGoogle Scholar
  21. 21.
    Vesikari T, Isolauri E, Delem A, D’Hondt E, André FE, Beards GM, Flewett TH (1985) Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr 107: 189–194PubMedCrossRefGoogle Scholar
  22. 22.
    Vesikari T, Isolauri E, Delem A, D’Hondt E, André FE, Zissis G (1983) Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet 2: 807–811PubMedCrossRefGoogle Scholar
  23. 23.
    Vesikari T, Isolauri E, D’Hondt E, Delem A, André FE (1984) Increased “take” rate of oral rotavirus vaccine in infants after milk feeding. Lancet ii: 700CrossRefGoogle Scholar
  24. 24.
    Vesikari T, Isolauri E, D’Hondt E, Delem A, André FE, Zissis G (1984) Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 1: 977–981PubMedCrossRefGoogle Scholar
  25. 25.
    Vesikari T, Kapikian AZ, Delem A, Zissis G (1986) A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children. J Infect Dis 153: 832–839PubMedCrossRefGoogle Scholar
  26. 26.
    Vesikari T, Rautanen T, Varis T, Beards GM, Kapikian AZ (1990) Clinical trial of rhesus rotavirus candidate vaccine (strain MMU 18006) in children vaccination between 2 and 5 months of age. Am J Dis Child 14: 285–289Google Scholar
  27. 27.
    Vesikari T, Ruuska T, Delem A, André FE, Beards GM, Flewett TH (1991) Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea. Acta Paediatr Scand 80: 173–180PubMedCrossRefGoogle Scholar
  28. 28.
    Vesikari T, Ruuska T, Delem A, André FE (1987) Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine: a preliminary report. Pediatr Infect Dis J 6: 164–169PubMedCrossRefGoogle Scholar
  29. 29.
    Vesikari T, Ruuska T, Delem A, André FE (1986) Oral rotavirus vaccination in breast-and bottle-fed infants aged 6 to 12 months. Acta Paediatr Scand 75: 573–578PubMedCrossRefGoogle Scholar
  30. 30.
    Vesikari T, Ruuska T, Green K, Flores J, Kapikian AZ (1992) Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity. Pediatr Infect Dis J 11: 535–542PubMedCrossRefGoogle Scholar
  31. 31.
    Vesikari T, Varis T, Green J, Kapikian AZ (1991) Immunogenicity and safety of rhesus-human reassortant vaccines with serotype 1 or 2 VP7 specificity. Vaccine 9: 334–339PubMedCrossRefGoogle Scholar
  32. 32.
    Vodopija I, Baklaic Z, Vlatkovic R, Bogaerts H, Delem A, André FE (1986) Combined vaccination with live oral poliovaccine and the bovine rotavirus RIT 4237 strain. Vaccine 4: 233–236PubMedCrossRefGoogle Scholar
  33. 33.
    Wilde J, Eiden J, Willoughby J (1991) Improved detection of rotavirus shedding by polymerase chain reaction. Lancet 337: 323–326PubMedCrossRefGoogle Scholar
  34. 34.
    Yosukawa M, Nakagomi O, Dobayaski Y (1990) Rotavirus induces proliferative response and augments non-specific cytotoxic activity of lymphocytes in humans. Clin Exp Immunol 80: 49–55CrossRefGoogle Scholar
  35. 35.
    Zheng BJ, Lo SKF, Tarn JSL, Lo M, Yeung CY, Ng MH (1989) Prospective study of community acquired rotavirus infection. J Clin Microbiol 27: 1939–1945PubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 1996

Authors and Affiliations

  • T. Vesikari
    • 1
  1. 1.Medical SchoolUniversity of TampereTampereFinland

Personalised recommendations